All In Biotech

Drug Trial Radar · NCT05813561

The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

A Multicenter, Randomized, Double-Blind, Active-Parallel-Controlled, Phase 3 Clinical Study to Investigate the Efficacy and Safety of DWP14012 in the Treatment of Reflux Esophagitis

Last checked: Nov 19, 2026Latest source record: Apr 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 332 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

332

Actual

Start

Dec 30, 2021

Primary completion

Jul 23, 2022

Study completion Feb 17, 2023

Sponsor

Sponsor type
Industry
First posted
Apr 14, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy, safety, and cost-effectiveness of DWP14012 40 mg compared to esomeprazole magnesium enteric-coated tablets for the treatment of reflux esophagitis.

Conditions

  • Reflux Esophagitis

Interventions

  • DWP14012Drug

    DWP14012 40mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. mucosal healing within 8 weeksTime frame: 8weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Minhu Chen

    Guangzhou, Guangdong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.